Related Experiment Video
Updated: Aug 21, 2025

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
Are SMAD2/4/7 genetic variants associated with rheumatoid arthritis susceptibility and severity?
Anna Wajda1, Barbara Stypińska2, Magdalena Czarnecka2
1Department of Molecular Biology, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland. annawajda2046@gmail.com.
Objectives:
SMADs play one of the key roles in the TGFβ signalling pathway. Therefore, through their involvement in the immune response as well as in the fibrosis process, these proteins appear to take on one of the essential functions in the pathogenesis of autoimmune connective tissue diseases such as RA. This study aimed to investigate the association of selected SNPs in SMAD2/4/7 with RA risk in the Caucasian population and disease course in RA patients.
Methods:
The study was conducted on 647 patients with established RA and 496 unrelated healthy controls (HCs). All patients fulfilled the American College of Rheumatology Diagnostic classification criteria for RA (ACR 1987). The analysis has been conducted using TaqMan genotyping assay. Transcript-inferred pathogenicity score (TraP-score) has been evaluated by TrapScore. PredictSNP.2 has been used to predict the effect of amino acid substitutions.
Results:
The present study revealed in SMAD4 a significantly higher frequency of AG rs12456284 (under codominant model OR=0.62 p=0.027 and overdominant model OR=0.59 p=0.016) and GA rs10502913 (under codominant model OR=0.65 p=0.050 and overdominant OR=0.64 p=0.033) genotypes in healthy subjects in comparison to RA patients. Additionally, very strong LD has been noted between these two genetic variants (D'=0.95 r2=0.90). Moreover, bioinformatic analysis classified rs12456284 as deleterious change with 94% prediction accuracy. SMAD2 rs1792666 and SMAD7 rs3736242 showed to have the highest association with disease course. SMAD4 rs10502913, SMAD7 rs3736242, and SMAD7 rs4464148 were associated with the concentration of creatinine.
Conclusions:
Our results suggested that rs12456284 and rs10502913 in SMAD4 may have a potential protective effect against RA. Particularly, SMAD2 rs1792666 and SMAD7 rs3736242 seem to be significantly associated with diseases course in RA patients in the Caucasian population.
Insights
Genetic variants in SMAD4 may offer protection against rheumatoid arthritis (RA). Specific SMAD2 and SMAD7 variants are linked to RA disease progression and creatinine levels in Caucasian patients.
Area of Science:
- Genetics
- Immunology
- Rheumatology
Background:
- SMAD proteins are crucial in TGF-beta signaling, influencing immune responses and fibrosis.
- Dysregulation of SMADs is implicated in autoimmune connective tissue diseases like rheumatoid arthritis (RA).
Purpose of the Study:
- To investigate the association of single nucleotide polymorphisms (SNPs) in SMAD2, SMAD4, and SMAD7 with RA risk.
- To examine the relationship between these SNPs and disease course in RA patients.
Main Methods:
- Genotyping of 647 RA patients and 496 healthy controls using TaqMan assay.
- Bioinformatic analysis including TraP-score and PredictSNP.2 for pathogenicity prediction.
- Association analysis with RA risk, disease course, and creatinine levels.
Main Results:
- SMAD4 genotypes (rs12456284 AG and rs10502913 GA) were more frequent in healthy individuals, suggesting a protective effect against RA.
- Strong linkage disequilibrium (LD) observed between rs12456284 and rs10502913 in SMAD4.
- SMAD2 rs1792666 and SMAD7 rs3736242 showed significant associations with RA disease course; SMAD4 rs10502913, SMAD7 rs3736242, and SMAD7 rs4464148 were linked to creatinine levels.
Conclusions:
- SMAD4 variants rs12456284 and rs10502913 may confer a protective effect against rheumatoid arthritis in the Caucasian population.
- SMAD2 rs1792666 and SMAD7 rs3736242 are significantly associated with the disease course of RA.
More Related Videos
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway
Single Nucleotide Polymorphisms-SNPs
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pleiotropy